Cargando…

Ribavirin therapy for severe COVID-19: a retrospective cohort study

The aim of this study was to compare ribavirin therapy versus supportive therapy only for patients with severe coronavirus disease 2019 (COVID-19). A total of 115 patients with laboratory-confirmed COVID-19 were retrospectively analysed. All patients received supportive care as well as regular labor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Song, Su, Yuan, Yu, Yuan, Wu, Chuangyan, Chen, Jiuling, Wang, Sihua, Jiang, Jinjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377772/ https://www.ncbi.nlm.nih.gov/pubmed/32712334 http://dx.doi.org/10.1016/j.ijantimicag.2020.106114

Ejemplares similares

The importance of overweight in COVID-19: A retrospective analysis in a single center of Wuhan, China
por: Rao, Xinrui, et al.
Publicado: (2020)

A retrospective analysis of clinical efficacy of ribavirin in adults hospitalized with severe COVID-19
por: Gong, Wei-Jing, et al.
Publicado: (2021)

Nomogram and risk calculator for severe hypoxemia after heart valve surgery
por: Ding, Xiangchao, et al.
Publicado: (2022)

Efficacy of ribavirin and interferon-α therapy for hospitalized patients with COVID-19: A multicenter, retrospective cohort study
por: Li, Hui, et al.
Publicado: (2021)

Inhibition of intimal hyperplasia in murine aortic allografts by administration of a small-molecule TLR4 inhibitor TAK-242
por: Wu, Chuangyan, et al.
Publicado: (2017)

A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia
por: Wang, Yin, et al.
Publicado: (2020)

Association between risk of venous thromboembolism and mortality in patients with COVID-19
por: Chen, Shujing, et al.
Publicado: (2021)

Effectiveness of adjunctive corticosteroid therapy in patients with severe COVID-19: A retrospective cohort study
por: Xiong, Bin, et al.
Publicado: (2021)

Effectiveness of Ribavirin and Corticosteroids for Severe Acute Respiratory Syndrome
por: Lau, Eric H.Y., et al.
Publicado: (2009)

Promising gas therapies for severe COVID-19
por: Wang, Ting, et al.
Publicado: (2021)

Nucleotide‐Binding Oligomerization Domain‐Like Receptor Protein 3 Deficiency in Vascular Smooth Muscle Cells Prevents Arteriovenous Fistula Failure Despite Chronic Kidney Disease
por: Ding, Xiangchao, et al.
Publicado: (2018)

A Retrospective Cohort Study: Safety and Effectiveness of Elbasvir/Grazoprevir ± Ribavirin Compared With Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir ± Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Infection
por: Hung, Hsuan-Yu, et al.
Publicado: (2021)

Ribavirin
Publicado: (2016)

Ribavirin
por: Hall, Caroline Breese
Publicado: (1985)

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
por: Omrani, Ali S, et al.
Publicado: (2014)

Inhibition of S-adenosyl-L-homocysteine hydrolase alleviates alloimmune response by down-regulating CD4(+) T-cell activation in a mouse heart transplantation model
por: Huang, Yajun, et al.
Publicado: (2020)

Safety of Sofosbuvir and Ribavirin Combination Therapy in a Patient Who Developed Anemia due to Ribavirin
por: Suii, Hirokazu, et al.
Publicado: (2017)

Regional differences in hepatitis C treatment with peginterferon and ribavirin in Japan: a retrospective cohort study
por: Ide, Kazuki, et al.
Publicado: (2016)

Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature
por: Sato, Ken, et al.
Publicado: (2019)

Effectiveness of Convalescent Plasma Therapy in Severe or Critically Ill COVID-19 Patients: A Retrospective Cohort Study
por: Cho, YunSuk, et al.
Publicado: (2021)

Effect of Sofosbuvir plus Ribavirin therapy on hepatitis C patients in Pakistan: a retrospective study
por: Jamil, Zubia, et al.
Publicado: (2018)

In vitro antiviral activity of ribavirin against severe fever with thrombocytopenia syndrome virus
por: Lee, Myung Jin, et al.
Publicado: (2017)

Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID‐19
por: Khalili, Jahan S., et al.
Publicado: (2020)

Ribavirin Treatment for Critically Ill COVID-19 Patients: An Observational Study
por: Xu, Yonghao, et al.
Publicado: (2021)

Severe community-acquired adenovirus pneumonia treated with oral ribavirin: a case report
por: Yoon, Byung Woo, et al.
Publicado: (2017)

Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy
por: Pradat, Pierre, et al.
Publicado: (2015)

Celiac Disease and the Susceptibility of COVID-19 and the Risk of Severe COVID-19: A Mendelian Randomization Study
por: Li, Jiuling, et al.
Publicado: (2022)

Chronic HCV treatment with peginterferon-ribavirin and severe tuberculosis re-activation
por: Manfredi, Roberto, et al.
Publicado: (2010)

Case report: Ribavirin and vitamin A in a severe case of measles
por: Bichon, Amandine, et al.
Publicado: (2017)

Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy: a retrospective, observational study
por: Franz, Anika, et al.
Publicado: (2023)

Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C
por: Karino, Y, et al.
Publicado: (2014)

Organizing Pneumonia Associated with Pegylated Interferon α and Ribavirin Therapy
por: Chopra, Amit, et al.
Publicado: (2015)

Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin
por: Feld, Jordan J., et al.
Publicado: (2018)

Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection
por: Gallacher, Jennifer, et al.
Publicado: (2023)

Long-term surveillance of liver histological changes in chronic hepatitis C patients completing pegylated interferon-α plus ribavirin therapy: an observational cohort study
por: Hsieh, Ming-Han, et al.
Publicado: (2022)

Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study
por: Kovari, Helen, et al.
Publicado: (2015)

RIBAVIRIN AND RESPIRATORY SYNCYTIAL VIRUS
Publicado: (1986)

Combination effects of ribavirin and interferons on severe fever with thrombocytopenia syndrome virus infection
por: Shimojima, Masayuki, et al.
Publicado: (2015)

Inflammation characteristics and anti-inflammation treatment with tocilizumab of severe/critical COVID-19 patients: A retrospective cohort study
por: Hu, Qin, et al.
Publicado: (2021)

Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial
por: Poulakou, Garyfallia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bl7tp6m26cv6chnj8nb37nhu36